News

August 2, 2021

Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories

Financial News

July 22, 2021

Inotiv, Inc. to Report Third Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, August 11, 2021

Corporate News

July 15, 2021

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

Corporate News

July 12, 2021

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio

Corporate News

June 28, 2021

Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort

Financial News

June 7, 2021

Inotiv Set to Join Russell 3000® Index and Russell 2000® Index

Corporate News

May 27, 2021

Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity

Corporate News

May 11, 2021

Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings

Financial News

May 5, 2021

Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results

Financial News

April 30, 2021

Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.